IntoCell is a company specializing in biomedicine R&D based on various platform technologies in the field of protein-drug conjugates. IntoCell develops unique linkers and drugs to apply towards protein-drug conjugates including antibody-drug conjugates. It is also developing proprietary protein-drug conjugates for the treatment of cancer.
